Company / Capital Returned to Shareholders per Share
Boston Scientific Capital Returned to Shareholders per Share History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders per Share
-
FY2024
5-year range
$0.00 / $0.04
FY2020-FY2024
Trend
-100.0%
vs FY2023
Sector context
#96 of 108
Health Care
What the data says
Declined from $0.04 to $0.00 over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 11% in Health CareTop 89% of 108
▼
Key checks
Key Insights
- In FY2024, capital returned to shareholders per share decreased 100.0% year-over-year.
- Peak capital returned to shareholders per share was recorded in FY2022.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to Shareholders per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $0.00 | -100.0% |
| FY2023 | $0.02 | -48.9% |
| FY2022 | $0.04 | - |
| FY2021 | $0.00 | - |
| FY2020 | $0.00 | - |
| FY2019 | $0.00 | - |
| FY2018 | $0.00 | - |
| FY2017 | - | - |
| FY2016 | $0.00 | - |
As of FY2024 · SEC 10-K · Updated Jul 2, 2026